FDA approves Breyanzi, a New CAR-T Cell Therapy for blood cancers
USA—The Food and Drug Administration of the United States has approved Breyanzi, a cell therapy...
Read MoreSelect Page
Mar 18, 2024
USA—The Food and Drug Administration of the United States has approved Breyanzi, a cell therapy...
Read MoreMar 18, 2024
USA—Rezdiffra has been approved by the Food and Drug Administration, marking a significant...
Read MoreMar 18, 2024
USA—The Pharmacy and Poisons Board (PPB) has achieved a significant milestone in regulatory...
Read MoreMar 18, 2024
KENYA—Kenya has launched the Resilient and Empowered African Community Health (REACH) program in...
Read MoreMar 17, 2024
KENYA—The Kenya Healthcare Federation (KHF), a Health Sector Board of the Kenya Private Sector...
Read MoreMar 17, 2024
USA—Mayo Clinic, a nonprofit American academic medical center dedicated to integrated healthcare,...
Read MoreMar 15, 2024
AFRICA—The Africa CDC has collaborated with the Wellcome Trust, a London-based nonprofit...
Read MoreMar 15, 2024
USA— Merck, an American multinational pharmaceutical firm based in Rahway, novel Jersey, has...
Read MoreMar 15, 2024
UK—AstraZeneca, a worldwide science-led biopharmaceutical firm based in Cambridge, UK, has...
Read MoreMar 15, 2024
SOUTH AFRICA—The African Association of Nephrology has reported that the prevalence of chronic...
Read More